Taylor Wessing advised the investors on Mission Zero Technologies’ Series A funding. Climate tech leader Mission Zero Technologies secured £21.8 million in Series A funding. Investors...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised ATL Technology. ATL Technology (ATL), a fast-growing provider of outsourced design, development and manufacturing services to the medical devices market, acquired the manufacturing...
You must be a Standard 1 Year member to access this content.
Marriott Harrison advised Oxford Science Enterprises and others on the deal. Taylor Wessing advised Prosus Ventures. In the £30 million Series A round participated Oxford Science Enterprises, Braavos Investment...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Shield Therapeutics plc on the deal. Shield Therapeutics plc, an AIM-listed commercial stage specialty pharmaceutical company, concluded its transformational collaboration agreement with global...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Five on the deal. Ashurst advised Robert Bosch GmbH. Five, Europe’s leading start-up for self-driving cars, has been sold to Bosch, one of...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised New Science Ventures on the deal. US deep-tech investor, New Science Ventures, acted as lead investor on Paragraf’s $60 million Series B funding round....
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Placid0 on the deal. Placid0 has been acquired by innovative eyecare brand, WALDO. Placid0 has created EASY, an eye assessment system mobile application,...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, thorugh its Series B financing, raised a...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised E Ink on the deal. Taylor Wessing advised Nuclera. E Ink, the leading innovator of electronic ink technology, announced the sale of its...
You must be a Standard 1 Year member to access this content.
